Carregant...
Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
BACKGROUND: The multi-arm multi-stage (MAMS) design described by Royston et al. [Stat Med. 2003;22(14):2239–56 and Trials. 2011;12:81] can accelerate treatment evaluation by comparing multiple treatments with a control in a single trial and stopping recruitment to arms not showing sufficient promise...
Guardat en:
| Publicat a: | Trials |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4930581/ https://ncbi.nlm.nih.gov/pubmed/27369182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1382-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|